SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News

One-third Of Americans Cut Back on Other Expenses to Cover Healthcare in 2025, Survey Shows

Roughly one-third of Americans cut back on food, utilities or other daily expenses to pay for healthcare last year, research ⁠from the West Health-Gallup Center showed on...

Insulet Recalls Some Insulin Devices in US Over Leakage Risk

Insulet has recalled specific batches of its insulin-delivery pods in the ⁠U.S. after finding a manufacturing defect that could stop diabetic users from ⁠getting their full...

Psychosocial Risk: Loneliness as a Diabetes Predictor

Pooled results from nine cohorts of 1 million people show loneliness raises type 2 diabetes risk by 32%; asking ‘Do you feel lonely?’ could inform preventive care.

Social Risk Alerts Prompt Better Blood Pressure Control

The intervention also involves adding Z codes to patient records.

GLP-1 Persistence for Weight Loss Has Nearly Doubled

Patients without diabetes treated with GLP-1s for weight loss are remaining on the drugs without gaps, and switching drugs when needed may help sustain persistence.

Intraperitoneal Insulin an Option for Select T1D Patients

An upcoming international position statement will clarify the small number of patients for whom the MiniMed Implantable Infusion Pump might be considered appropriate.

Todays Updates

Winter Sports and Lower Limb Motor Disability

People with lower limb motor disability need tailored equipment, training, and medical oversight to boost performance while preventing upper limb overload and skin problems.

Can Better Screening Prevent Maternal VTE Deaths?

Nearly half of maternal deaths from venous thromboembolism in France over 12 years were preventable.

'Concerning': CRC Continues to Shift Toward Younger Adults

Nearly half of new colorectal cancer cases now occur in people younger than age 65 years, highlighting the need for earlier screening and better symptom awareness.

Tight Glycemic Target in Gestational Diabetes Reduces Risks

Tight glycemic targets in gestational diabetes can lower the risk for large-for-gestational-age births without increasing the risk for serious maternal and neonatal complications.

Todays Updates

Winter Sports and Lower Limb Motor Disability

People with lower limb motor disability need tailored equipment, training, and medical oversight to boost performance while preventing upper limb overload and skin problems.

Can Better Screening Prevent Maternal VTE Deaths?

Nearly half of maternal deaths from venous thromboembolism in France over 12 years were preventable.

'Concerning': CRC Continues to Shift Toward Younger Adults

Nearly half of new colorectal cancer cases now occur in people younger than age 65 years, highlighting the need for earlier screening and better symptom awareness.

Tight Glycemic Target in Gestational Diabetes Reduces Risks

Tight glycemic targets in gestational diabetes can lower the risk for large-for-gestational-age births without increasing the risk for serious maternal and neonatal complications.

Latest News

Roughly one-third of Americans cut back on food, utilities or other daily expenses to pay for healthcare last year, research ⁠from the West Health-Gallup Center showed on...

Insulet has recalled specific batches of its insulin-delivery pods in the ⁠U.S. after finding a manufacturing defect that could stop diabetic users from ⁠getting their full...

Pooled results from nine cohorts of 1 million people show loneliness raises type 2 diabetes risk by 32%; asking ‘Do you feel lonely?’ could inform preventive care.

The intervention also involves adding Z codes to patient records.

Patients without diabetes treated with GLP-1s for weight loss are remaining on the drugs without gaps, and switching drugs when needed may help sustain persistence.

An upcoming international position statement will clarify the small number of patients for whom the MiniMed Implantable Infusion Pump might be considered appropriate.

News All Time

GLP-1s Effective for Migraine Management?

Real-world data suggest GLP-1 receptor agonists may reduce emergency care visits and the need for additional migraine treatments in adults with chronic migraine.

Bariatric Surgery Reduces Sleep Apnea Long Term

In adults with obesity, bariatric surgery is linked to a higher sleep apnea remission rate and fewer new cases of obstructive sleep apnea over 20 years than usual obesity care.

Predicting Early Weight Regain After Sleeve Gastrectomy

Lower preoperative BMI and suboptimal 12-month weight loss are linked to rapid weight regain within 2 years after sleeve gastrectomy.

Lindt Says Weight-loss Drugs Users Are Eating More Chocolate, Not Less

Chocolate sales are rising faster among U.S. users of GLP-1 weight-loss drugs ⁠than in the rest of the population, Swiss chocolatier Lindt & Spruengli said on Tuesday,...

When Lab Reference Values May Mislead Clinicians

Laboratory reference ranges reflect methods, populations, and policies, and experienced clinicians interpret them in context rather than applying fixed cutoffs theoretically.

Targeted Brain Tumour Drug Approved for NHS Scotland

Scotland has approved the targeted therapy vorasidenib for some low-grade brain tumours, while NICE in England continues to review its cost-effectiveness.

Novo and Hims to Sell Obesity Drugs Together as Feud Ends, Bloomberg News Reports

Wegovy maker Novo Nordisk plans to sell its weight-loss drugs on ⁠Hims & Hers Health platform, bringing an end to a dispute between the ⁠two companies that escalated...

Women at Higher Risk for Smoking Relapse Than Men

Women face biological, hormonal, and psychosocial factors that complicate smoking cessation, prompting experts to call for sex-specific strategies to improve quit success.

How Policy and New Drugs Reshaped Obesity Treatment

The 2013 declaration of obesity as a chronic disease and the 2021 approval of semaglutide are associated with increased use of antiobesity medications, while bariatric surgery rates remain stable.

Self-Insulin Dosing Leads to Control in Gestational Diabetes

In individuals with gestational diabetes, patient-led insulin titration is linked to faster glycemic control and a lower risk for macrosomia than clinician-led approaches.

Chemical Exposure Detected in Semen Linked to Sperm Quality

High-resolution mass spectrometry identifies 42 nonvolatile organic compounds in semen samples from healthy young men.

Some US Medical Schools to Teach Nutrition Under Government Deal

About a fourth of U.S. medical schools will expand their nutrition education offerings this autumn as part of a ⁠deal with the administration of President Donald Trump, said...

China Approves Pfizer GLP-1 Drug for Weight Loss

China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in ⁠overweight or obese adults, the U.S. drugmaker said on Friday.

Roche, Zealand's Obesity Drug Shows Up to 10.7% Weight Loss in Mid-stage Trial

Roche said on Thursday its experimental obesity drug, which it is developing with Denmark's Zealand Pharma, helped patients ⁠lose up to 10.7% of their body weight in a...

Autonomic Dysfunction: A Hidden Driver of Gastroparesis?

Multimodal physiologic testing in patients with chronic gastroduodenal symptoms reveals autonomic dysfunction and links it to delayed gastric emptying.

Tendon Rupture Risk Linked With GLP-1 Use in Obese Patients

5-year findings call for physicians to balance the benefits of the medication for weight loss with the rupture risks, particularly for tendons that do the heavy lifting.

Recommended News For You

Doctor Suspected of Murder; Cancer Blood Test Under Fire; TikTok and Body Image

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

Researchers discuss HER2-low and HER2-zero in breast cancer

Sports for girls are frequently abandoned due to uniform issues.

Using MRD Status to Deescalate Multiple Myeloma Therapy

A new FDA boxed warning; suicides rocking college campuses; more people getting flu shots than COVID vaccines.

Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities

Recommended Articles For You

Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis 

Liquid Biopsy: Revolutionizing Precision Oncology in Hematological Malignancies 

Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology 

Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Headlines About Doc Who 'Catches' Patient's Cancer Are Popping Up Again

2.

Can taking vitamin D supplements every day lower the mortality rate from cancer?

3.

Legal, Recreational Marijuana Linked to Higher CUD Prevalence.

4.

Thriving while surviving: Understanding the social needs of cancer survivors

5.

Cabozantinib Improves PFS for Advanced Neuroendocrine Tumors

1.

Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning 

2.

Case Study: Genomic Medicine in Precision Oncology

3.

Everything You Need To Know About Trichelemmal Cysts: Symptoms, Causes, Diagnosis And Treatment

4.

How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?

5.

The Growing Challenge of Haematological Malignancies in Older Adults

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

2.

A New Era in Managing Cancer-Associated Thrombosis

3.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

4.

Navigating the Complexities of Ph Negative ALL - Part V

5.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot